Paul Bisaro Net Worth & Insider Trades
Paul Bisaro - Director, Therapeuticsmd, Inc
What is Paul Bisaro's Net Worth?
The current estimated net worth of Therapeuticsmd, Inc's Director, Paul Bisaro, is estimated to be about $63.24M . Paul Bisaro owns about 196,864 units of Therapeuticsmd, Inc common stock. In the last year at Therapeuticsmd, Inc, Paul Bisaro has sold an estimated value of $0 worth.
What is Paul Bisaro's Past Insider Trading?
Paul Bisaro's largest purchase order was 50,000 units , worth over $57K on June 8, 2020. In total, Paul Bisaro has made about 5 transactions over a year of their time at Therapeuticsmd, Inc. Paul Bisaro usually trades in August and June, with the busiest year in 2021. The most recent transaction was a purchase order of 50,000 units , worth over $39.5K on August 18, 2021.
Paul Bisaro
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Therapeuticsmd, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Robert G. Finizio | 2020 | $600,000 | $1,524,751 | - | $600,000 | $21,785 | $2,746,536 |
| Robert G. Finizio | 2019 | $600,000 | - | $2 | $600,000 | $22,218 | $1,222,220 |
| John C.K. Milligan, IV | 2020 | $450,000 | $1,479,105 | - | $315,000 | $31,285 | $2,275,390 |
| John C.K. Milligan, IV | 2019 | $450,000 | - | $645,956 | $315,000 | $29,683 | $1,440,639 |
| Edward Borkowski | 2020 | $430,000 | - | $3,599,967 | $365,500 | $81,687 | $4,477,154 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/25743/000119312521116458/d152560ddef14a.htm
What are Therapeuticsmd, Inc's Past Insider Trades?
Therapeuticsmd, Inc's most recent insider trade came on August 1, 2022 by Rubric Capital Management Lp and Efraim David Rosen who bought 580,000 units worth $15M . In the last 9 years, insiders at Therapeuticsmd, Inc have sold an estimated value of $50.32M and bought an estimated value of $20.27M worth of shares. Insider trading is most common in March, with the busiest year in 2018. The most active traders at the company are John C.K. Milligan IV, Secretary/CEO subsidiary, Robert G Finizio, CEO, and Tommy G Thompson, Director .
TherapeuticsMD, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||